Skip to content
The People's CodeSearch
Menu

S. 5237 · Senate bill · 119th Congress

Stop Superbugs Act

  1. Introduced
  2. In committeeHealth, Education, Labor, and Pensions
  3. Passed the Senate (not yet)
  4. Passed the House (not yet)
  5. Law (not yet)

What it says

About this text

Text: , (the only version so far)

Official text on Congress.gov

This bill creates or directs, rather than amending the Code.

Its own words follow, as Congress.gov publishes them.

Sec. 1. Short title This Act may be cited as the Stop Superbugs Act.

Sec. 2. Funding for antibiotic resistance clinical research

(a) In general The Director of the National Institute of Allergy and Infectious Diseases shall award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, which shall include focuses on—

(1) supporting rapid recruitment of clinical trial participants;

(2) conducting clinical trial recruitment outreach in community settings;

(3) supporting the pairing of diagnostic and pharmaceutical innovations during clinical trials; and

(4) developing patient-reported outcomes in clinical studies.

(b) Authorization of appropriations There is authorized to be appropriated to the Director of the National Institute of Allergy and Infectious Diseases such sums as may be necessary to carry out subsection (a).